Skip to main content
Log in

AHF latest to challenge Gilead's hep-C drug price

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. see PharmacoEconomics & Outcomes News 712 p36; 803108370

Reference

  • AIDS Healthcare Foundation. AHF to Gilead: Have You No Shame? Pricing New Hepatitis C Drug Above $84K. Media Release : 23 Sep 2014. Available from: URL: http://www.aidshealth.org

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AHF latest to challenge Gilead's hep-C drug price. PharmacoEcon Outcomes News 713, 1 (2014). https://doi.org/10.1007/s40274-014-1586-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1586-4

Navigation